Recent Finacing
Recent Raise
Avexegen Therapeutics is a San Francisco–based private biotech developing Neuregulin‑4 (NRG‑4) therapies for gastrointestinal disorders, conducting preclinical studies on anti‑inflammatory and epithelial‑healing delivery approaches.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor